NAT-LENALIDOMIDE

Identification of Nat-Lenalidomide

No description

Google image searchProduct monograph

Active ingredient

lenalidomide, 20 MG

DIN: 02493896

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: NATCO PHARMA (CANADA) INC

Date: 01-SEP-2021

ATC:

Reference brand drug: Revlimid

Search on Google